Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.
Journal: Molecular cancer therapeutics
Published: October 01, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 18, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.
Journal: Cancer discovery
Published: August 18, 2023
Total neoadjuvant therapy for locally advanced gastric cancer: too much of a good thing?
Journal: Journal of gastrointestinal oncology
Published: August 16, 2023
Contemporary Cancer Program Practice Profile Report Compliance Rates for Gastric Cancer: A National Cancer Database Analysis.
Journal: The American surgeon
Published: June 06, 2023
Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
Journal: Journal of neuroendocrinology
Published: June 05, 2023
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.
Journal: Journal of hepatology
Published: May 18, 2023
Socioeconomic disparities in patients with small bowel neuroendocrine tumors.
Journal: Journal of surgical oncology
Published: April 14, 2023
Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan.
Journal: NPJ breast cancer
Published: January 17, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 13, 2023
Discordance of HER2 Expression and/or Amplification on Repeat Testing.
Journal: Molecular cancer therapeutics
Published: December 02, 2022
Last Updated: 09/26/2026